Novavax reports positive results for respiratory syncytial virus vaccine candidate

by Pat Dulnier on January 14, 2010

Rsv

RSV

ROCKVILLE, Md. — Novavax Inc. announced Jan. 12 that it has completed a pre-clinical safety and efficacy study of its RSV vaccine candidate in cotton rats.